<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:chebi fb="9" ids="15355">acetylcholine</z:chebi>-activated <z:chebi fb="0" ids="29103">K(+)</z:chebi> current (I(K,<z:chebi fb="0" ids="15355">ACh</z:chebi>)) is a novel candidate for atrial-specific antiarrhythmic therapy </plain></SENT>
<SENT sid="1" pm="."><plain>The present study investigates the involvement of I(K,<z:chebi fb="0" ids="15355">ACh</z:chebi>) in <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) using NTC-801, a novel potent and selective I(K,<z:chebi fb="0" ids="15355">ACh</z:chebi>) blocker </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: The effects of NTC-801, substituted 4-(aralkylamino)-2,2-dimethyl-3,4-dihydro-2H-<z:chebi fb="0" ids="22727">benzopyran</z:chebi>-3-ol, on I(K,<z:chebi fb="0" ids="15355">ACh</z:chebi>) and other cardiac ionic currents (I(Na), I(CaL), I(to), I(Kur), I(Kr), I(Ks), I(Kl), I(KATP), and I(f)) and on atrial and ventricular action potentials were examined in vitro </plain></SENT>
<SENT sid="3" pm="."><plain>NTC-801 potently inhibited <z:chebi fb="0" ids="3385">carbachol</z:chebi>-induced I(K,<z:chebi fb="0" ids="15355">ACh</z:chebi>) in guinea pig atrial cells and the GIRK1/4 current in Xenopus oocytes with IC(50) values of 5.7 and 0.70 nmol/L, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>NTC-801 selectively inhibited I(K,<z:chebi fb="0" ids="15355">ACh</z:chebi>) &gt;1000-fold over other cardiac ionic currents </plain></SENT>
<SENT sid="5" pm="."><plain>NTC-801 (10 to 100 nmol/L) reversed the action potential duration (APD(90)) shortened by <z:chebi fb="0" ids="3385">carbachol</z:chebi> or <z:chebi fb="3" ids="16335">adenosine</z:chebi> in atrial cells, whereas it did not affect APD(90) at 100 nmol/L in ventricular cells </plain></SENT>
<SENT sid="6" pm="."><plain>Antiarrhythmic effects of NTC-801 were evaluated in 3 AF models in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>NTC-801 significantly prolonged atrial effective refractory period without affecting ventricular effective refractory period under vagal nerve stimulation </plain></SENT>
<SENT sid="8" pm="."><plain>NTC-801 dose-dependently converted AF to <z:mpath ids='MPATH_458'>normal</z:mpath> sinus rhythm in both vagal nerve stimulation-induced (0.3 to 3 μg · kg(-1) · min(-1) IV) and <z:chebi fb="0" ids="2430">aconitine</z:chebi>-induced (0.01 to 0.1 mg/kg IV) models </plain></SENT>
<SENT sid="9" pm="."><plain>In a rapid atrial pacing model, NTC-801 (3 μg · kg(-1) · min(-1) IV) significantly decreased AF inducibility with a prolonged atrial effective refractory period that was frequency-independent </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: A selective I(K,<z:chebi fb="0" ids="15355">ACh</z:chebi>) blockade induced by NTC-801 exerted anti-AF effects mediated by atrial-selective effective refractory period prolongation </plain></SENT>
<SENT sid="11" pm="."><plain>These findings suggest that I(K,<z:chebi fb="0" ids="15355">ACh</z:chebi>) may be important in the development and maintenance of AF </plain></SENT>
</text></document>